ANI Pharmaceuticals (NASDAQ:ANIP) and Tower One Wireless (OTCMKTS:TOWTF) Head to Head Contrast

ANI Pharmaceuticals (NASDAQ:ANIPGet Rating) and Tower One Wireless (OTCMKTS:TOWTFGet Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Institutional & Insider Ownership

59.7% of ANI Pharmaceuticals shares are held by institutional investors. 27.2% of ANI Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


This table compares ANI Pharmaceuticals and Tower One Wireless’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ANI Pharmaceuticals -19.71% 14.10% 5.94%
Tower One Wireless -19.47% N/A -7.47%

Earnings & Valuation

This table compares ANI Pharmaceuticals and Tower One Wireless’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ANI Pharmaceuticals $216.14 million 2.26 -$42.60 million ($3.25) -8.70
Tower One Wireless $6.81 million 1.10 -$1.76 million ($0.01) -6.30

Tower One Wireless has lower revenue, but higher earnings than ANI Pharmaceuticals. ANI Pharmaceuticals is trading at a lower price-to-earnings ratio than Tower One Wireless, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and target prices for ANI Pharmaceuticals and Tower One Wireless, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANI Pharmaceuticals 0 1 2 0 2.67
Tower One Wireless 0 0 0 0 N/A

ANI Pharmaceuticals currently has a consensus target price of $58.50, indicating a potential upside of 106.86%. Given ANI Pharmaceuticals’ higher probable upside, equities research analysts clearly believe ANI Pharmaceuticals is more favorable than Tower One Wireless.

Volatility & Risk

ANI Pharmaceuticals has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Tower One Wireless has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500.


ANI Pharmaceuticals beats Tower One Wireless on 9 of the 12 factors compared between the two stocks.

About ANI Pharmaceuticals (Get Rating)

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

About Tower One Wireless (Get Rating)

Tower One Wireless Corp. owns, develops, and operates build-to-suit multitenant communications structures in Argentina, Colombia, Mexico, the United States, and internationally. It engages in the leasing of space on communications sites to mobile network operators. The company also provides tower-related services, including site acquisition, zoning and permitting, structural analysis, and construction. Tower One Wireless Corp. was founded in 2015 and is based in Vancouver, Canada.

Receive News & Ratings for ANI Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANI Pharmaceuticals and related companies with's FREE daily email newsletter.